```html

Mumps‑Associated Orchitis: A Comprehensive Patient Guide

Overview

Mumps‑associated orchitis is inflammation of one or both testes that occurs as a complication of infection with the mumps virus (a member of the Paramyxoviridae family). The condition most often appears in post‑pubertal males, typically within a week after the classic mumps symptoms (fever, parotid gland swelling) begin.

Key points

• Who it affects: Unvaccinated or partially vaccinated adolescent and adult males; rare in pre‑pubertal boys.
• Prevalence: Orchitis occurs in 20‑30 % of post‑pubertal males with mumps infection. In regions with high MMR (measles‑mumps‑rubella) vaccine coverage, overall cases have dropped >95 % since the 1970s (CDC, 2023).
• Why it matters: Testicular inflammation can lead to pain, temporary infertility, and, in rare cases, permanent loss of sperm production.

Understanding the signs, diagnosis, and management can help protect reproductive health and reduce complications.

Symptoms

Orchitis usually follows the typical mumps prodrome and may be unilateral (one testis) or bilateral (both testes). The symptom timeline often looks like this:

Early (1–3 days after mumps onset)

• Scrotal pain: Dull to severe, worsens with movement or elevation of the testis.
• Testicular swelling: The affected scrotum becomes enlarged, firm, and tender.
• Redness of scrotal skin: May appear as a pinkish hue; erythema is usually mild.

Associated systemic signs

• Fever (often 38–40 °C / 100.4–104 °F)
• Headache, malaise, and loss of appetite
• Parotid gland swelling (the classic “puffy cheeks” of mumps)
• Occasional nausea or vomiting

Later (4–7 days)

• Persisting pain that may radiate to the groin or lower abdomen
• Hydrocele formation (fluid collection around the testis) in up to 10 % of cases
• Transient decrease in libido or sexual discomfort

Red‑flag symptoms that warrant immediate evaluation

• Sudden, severe scrotal pain with a high fever (>39 °C)
• Rapidly expanding swelling, skin discoloration, or foul odor (suggesting bacterial super‑infection)
• Nausea/vomiting with dizziness (possible testicular torsion)

Causes and Risk Factors

Primary cause

The mumps virus spreads via respiratory droplets and, after an incubation period of 16–25 days, infects the salivary glands. In post‑pubertal males, the virus can disseminate hematogenously to the testes, triggering an inflammatory response that damages the seminiferous epithelium.

Risk factors

• Age: 15‑25 years old have the highest risk; orchitis is rare in boys <10 years.
• Vaccination status: Unvaccinated or only one dose of MMR vaccine increases susceptibility. Two‑dose coverage >95 % reduces orchitis risk to <1 % (WHO, 2022).
• Immune status: Immunocompromised individuals (e.g., on chemotherapy) may experience more severe disease.
• Close contact settings: College dorms, military barracks, and crowded schools facilitate transmission.
• Previous mumps infection: Rarely, reinfection can occur, especially if immunity wanes.

Diagnosis

Because orchitis is a clinical diagnosis, physicians combine a thorough history with a focused physical exam. The goal is to confirm mumps‑related inflammation and rule out other causes of acute scrotal pain (e.g., testicular torsion, epididymitis, bacterial orchitis).

Step‑by‑step diagnostic approach

1. History taking: Recent fever, parotid swelling, vaccination record, and exposure to known mumps cases.
2. Physical examination: Palpation of the testes for tenderness, swelling, and consistency; evaluation of the cremasteric reflex.
3. Laboratory tests:
   • Serum mumps IgM/IgG antibodies: Positive IgM indicates recent infection.
   • Complete blood count (CBC): May show mild leukocytosis.
   • Urinalysis: Rules out urinary tract infection that could cause epididymitis.
4. Imaging:
   • Scrotal ultrasound with Doppler: Shows an enlarged, hypoechoic testis with increased blood flow (hyperemia). It also helps exclude torsion, which shows decreased flow.
   • Chest X‑ray (rare): If respiratory symptoms suggest concurrent pneumonia.

Most cases are confirmed by clinical findings plus a positive serology. Ultrasound is essential when the presentation is atypical or when emergent conditions cannot be excluded.

Treatment Options

There is no antiviral specifically approved for mumps, so management focuses on symptom relief, preventing complications, and supporting recovery.

Medications

• Pain control: Acetaminophen (Tylenol) or ibuprofen (Advil, Motrin) 400–600 mg every 6–8 h as needed (avoid aspirin in children/teens). NSAIDs also reduce inflammation.
• Hydration and antipyretics: Oral fluids and antipyretics keep fever under 38.5 °C.
• Antibiotics: Not routinely indicated for viral orchitis, but prescribed if secondary bacterial infection is suspected (e.g., cellulitis).
• Corticosteroids: Occasionally used in severe cases to decrease inflammation, though evidence is limited and not routinely recommended.

Procedural interventions

• Scrotal support: An athletic supporter or snug underwear reduces stretching of the spermatic cord.
• Ice packs: Apply wrapped ice for 15 minutes, 3–4 times daily during the first 48 hours.
• Drainage of hydrocele: Rarely needed; performed by urologist if fluid accumulation causes discomfort.

Lifestyle and supportive measures

• Rest and limit strenuous activity (especially weightlifting, cycling, or prolonged sitting) for 2–3 weeks.
• Elevate the scrotum with a folded towel while lying down.
• Maintain good genital hygiene; gentle cleansing with warm water prevents secondary infection.
• Stay sexually abstinent until pain resolves to avoid exacerbating inflammation.

Living with Mumps‑Associated Orchitis

Most men recover fully within 2–3 weeks, but the period can be uncomfortable and emotionally stressful.

Daily management tips

• Pain diary: Record intensity, timing, and response to medication; helps clinicians adjust treatment.
• Comfortable clothing: Loose cotton underwear and breathable fabrics minimize moisture and friction.
• Cold‑compress routine: 15‑minute intervals, allowing skin to return to normal temperature between applications.
• Physical activity: Light walking is fine; avoid heavy lifting, running, or cycling until pain is <3/10.
• Nutrition: Include anti‑inflammatory foods (omega‑3 fatty acids, berries, leafy greens) and stay well‑hydrated.
• Follow‑up semen analysis: For men concerned about fertility, a semen analysis 3–6 months after recovery can assess sperm count and motility.

Psychosocial considerations

Concern about fertility is common. Reassure patients that permanent infertility occurs in <1 % of cases when orchitis is treated promptly (CDC, 2022). Offering counseling or referral to a reproductive specialist can alleviate anxiety.

Prevention

Because orchitis is a complication of mumps, preventing the viral infection is the most effective strategy.

• MMR vaccination: Two‑dose schedule at 12–15 months and 4–6 years. The CDC reports >99 % effectiveness at preventing mumps after two doses.
• Booster doses: In outbreak settings (e.g., college campuses), a third dose of MMR is recommended for at‑risk populations.
• Hand hygiene and respiratory etiquette: Frequent handwashing, using tissues, and covering coughs reduce viral spread.
• Avoid close contact: Stay away from individuals with parotitis or known mumps infection until they are no longer contagious (usually 5 days after onset of parotid swelling).
• Isolation: Infected persons should limit school or work attendance for at least 5 days after the onset of parotid swelling.

Complications

While most recover without lasting effects, untreated or severe orchitis can lead to:

• Infertility: Permanent damage to the seminiferous tubules in ~0.5–1 % of cases.
• Testicular atrophy: Shrinkage of the affected testis, often detectable on physical exam or ultrasound.
• Hydrocele or varicocele formation: Fluid accumulation may require surgical intervention.
• Abscess formation: Rare bacterial superinfection that may need drainage.
• Chronic scrotal pain: Persistent pain beyond 3 months, sometimes requiring pain‑management referral.

When to Seek Emergency Care

---

Sources: CDC. “Mumps (Rubeola) – Epidemiology.” 2023; WHO. “Measles‑Mumps‑Rubella (MMR) Vaccine.” 2022; Mayo Clinic. “Orchitis: Symptoms & Causes.” 2024; Cleveland Clinic. “Mumps‑Associated Orchitis.” 2023; National Institutes of Health. “Mumps Virus.” 2024.

```